Tech Company Financing Transactions

Francis Medical Funding Round

Francis Medical closed a $55 million Series B financing round on 9/17/2021. Investors included Solas Bioventures, Arboretum Ventures and Coloplast.

Transaction Overview

Company Name
Announced On
9/17/2021
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to fund for the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer, scheduled to begin enrollment in August 2022.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7351 Kirkwood Ln. N. 130
Maple Grove, MN 55369
USA
Email Address
Overview
Francis Medical is developing novel, disruptive therapeutic solutions to treat prostate, kidney and bladder cancer. Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer, yet gentle on patients. Our work is fueled by a compassionate belief that cancer can be stopped with minimally invasive treatments.
Profile
Francis Medical LinkedIn Company Profile
Social Media
Francis Medical Company Twitter Account
Company News
Francis Medical News
Facebook
Francis Medical on Facebook
YouTube
Francis Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Kujak
  Michael Kujak LinkedIn Profile  Michael Kujak Twitter Account  Michael Kujak News  Michael Kujak on Facebook
Chief Technical Officer
Michael Hoey
  Michael Hoey LinkedIn Profile  Michael Hoey Twitter Account  Michael Hoey News  Michael Hoey on Facebook
VP - Finance
Michael Fredrick
  Michael Fredrick LinkedIn Profile  Michael Fredrick Twitter Account  Michael Fredrick News  Michael Fredrick on Facebook
VP - Marketing
Richard Hill
  Richard Hill LinkedIn Profile  Richard Hill Twitter Account  Richard Hill News  Richard Hill on Facebook
VP - R & D
David Francischelli
  David Francischelli LinkedIn Profile  David Francischelli Twitter Account  David Francischelli News  David Francischelli on Facebook
VP - Regulatory Affairs
Joel Phillips
  Joel Phillips LinkedIn Profile  Joel Phillips Twitter Account  Joel Phillips News  Joel Phillips on Facebook
VP - Regulatory Affairs
Michele Shepard
  Michele Shepard LinkedIn Profile  Michele Shepard Twitter Account  Michele Shepard News  Michele Shepard on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/17/2021: Stardust venture capital transaction
Next: 9/17/2021: Outer venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary